Literature DB >> 17450506

Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation.

Eun-Kyung Park1, Hae In Rhee, Hye-Sook Jung, Seoung Min Ju, Yeon-Ah Lee, Sang-Hoon Lee, Seung-Jae Hong, Hyung-In Yang, Myung-Chul Yoo, Kyoung Soo Kim.   

Abstract

In an attempt to develop an antiinflammatory herbal remedy that is as potent as current synthetic medicines, the cortex of Phellodendron amurense Rupr (Rutaceae) and the rhizomes of Coptis chinensis Franch (Ranunculaceae) were combined in a 2:1 ratio. This ratio was chosen based on in vitro experiments and traditional Asian medicine prescriptions. The combined ethanol extract, named RAH13, was evaluated for antiinflammatory properties using animal models of acute inflammation such as the croton oil-induced ear edema test and an acetic acid-induced capillary permeability test. Models of chronic inflammation were also tested using the cotton pellet test and a delayed-type hypersensitivity (DTH) test. Oral administration of RAH13 at a dose of 200 mg/kg showed in vivo antiinflammatory activity as potent as the effects associated with 100 mg/mL of celecoxib or 1 mg/kg of dexamethasone. These effects were seen in both acute and chronic inflammation models, suggesting that RAH13 may be effective in controlling some inflammation-related diseases. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17450506     DOI: 10.1002/ptr.2156

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

Review 1.  Recent technological advances in the management of chronic wounds: A literature review.

Authors:  Benson G Ongarora
Journal:  Health Sci Rep       Date:  2022-05-19

2.  Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway.

Authors:  Andrew Remppis; Florian Bea; Henry Johannes Greten; Annette Buttler; Hongjie Wang; Qianxing Zhou; Michael R Preusch; Ronny Enk; Robert Ehehalt; Hugo Katus; Erwin Blessing
Journal:  Mediators Inflamm       Date:  2010-06-21       Impact factor: 4.711

3.  Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo.

Authors:  Zhonghan Yang; Viktoriya Grinchuk; Siu Po Ip; Chun-Tao Che; Harry H S Fong; Lixing Lao; Justin C Wu; Joseph J Sung; Brian Berman; Terez Shea-Donohue; Aiping Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-22       Impact factor: 2.629

4.  Possible inhibitor from traditional Chinese medicine for the β form of calcium-dependent protein kinase type II in the treatment of major depressive disorder.

Authors:  Tzu-Chieh Hung; Wen-Yuan Lee; Kuen-Bao Chen; Hung-Jin Huang; Yueh-Chiu Chan; Cheng-Chun Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

5.  Anti-inflammatory activity of bartogenic acid containing fraction of fruits of Barringtonia racemosa Roxb. in acute and chronic animal models of inflammation.

Authors:  Kalpesh R Patil; Chandragouda R Patil
Journal:  J Tradit Complement Med       Date:  2016-04-04

6.  Composition and diversity of rhizosphere fungal community in Coptis chinensis Franch. continuous cropping fields.

Authors:  Xuhong Song; Yuan Pan; Longyun Li; Xiaoli Wu; Yu Wang
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

7.  Phellodendron amurense and Its Major Alkaloid Compound, Berberine Ameliorates Scopolamine-Induced Neuronal Impairment and Memory Dysfunction in Rats.

Authors:  Bombi Lee; Bongjun Sur; Insop Shim; Hyejung Lee; Dae-Hyun Hahm
Journal:  Korean J Physiol Pharmacol       Date:  2012-04-24       Impact factor: 2.016

8.  The inhibition of folylpolyglutamate synthetase (folC) in the prevention of drug resistance in Mycobacterium tuberculosis by traditional Chinese medicine.

Authors:  Tzu-Chieh Hung; Kuen-Bao Chen; Wen-Yuan Lee; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.